These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23935769)

  • 21. Active HPV infection and its influence on survival in head and neck squamous-cell cancer.
    Janecka-Widła A; Mucha-Małecka A; Majchrzyk K; Halaszka K; Przewoźnik M; Słonina D; Biesaga B
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1677-1692. PubMed ID: 32372145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum HPV16 E7 Oncoprotein Is a Recurrence Marker of Oropharyngeal Squamous Cell Carcinomas.
    Oton-Gonzalez L; Rotondo JC; Lanzillotti C; Mazzoni E; Bononi I; Iaquinta MR; Cerritelli L; Malagutti N; Ciorba A; Bianchini C; Pelucchi S; Tognon M; Martini F
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
    Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
    J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of p16 and its relationship with human papillomavirus in pharyngeal squamous cell carcinomas.
    Wilson DD; Crandley EF; Sim A; Stelow EB; Majithia N; Shonka DC; Jameson MJ; Levine PA; Read PW
    JAMA Otolaryngol Head Neck Surg; 2014 Jul; 140(7):647-53. PubMed ID: 24876098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.
    Hauck F; Oliveira-Silva M; Dreyer JH; Perrusi VJ; Arcuri RA; Hassan R; Bonvicino CR; Barros MH; Niedobitek G
    Virchows Arch; 2015 Jun; 466(6):685-93. PubMed ID: 25820374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 29. Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: Exposing the limitations of conventional p16 immunostaining.
    El-Salem F; Mansour M; Gitman M; Miles BA; Posner MR; Bakst RL; Genden EM; Westra WH
    Oral Oncol; 2019 Mar; 90():74-79. PubMed ID: 30846180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Human Papillomavirus (HPV) Infection and the Association with Survival in Saudi Patients with Head and Neck Squamous Cell Carcinoma.
    Alsbeih G; Al-Harbi N; Bin Judia S; Al-Qahtani W; Khoja H; El-Sebaie M; Tulbah A
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31200489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer.
    Hashida Y; Higuchi T; Matsumoto S; Iguchi M; Murakami I; Hyodo M; Daibata M
    Cancer Sci; 2021 Oct; 112(10):4404-4417. PubMed ID: 34382311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
    Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Bauwens L; Baltres A; Fiani DJ; Zrounba P; Buiret G; Fleury B; Benzerdjeb N; Grégoire V
    Radiother Oncol; 2021 Apr; 157():122-129. PubMed ID: 33545255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of p16 expression and HPV type with survival in oropharyngeal squamous cell cancer.
    Liu SZ; Zandberg DP; Schumaker LM; Papadimitriou JC; Cullen KJ
    Oral Oncol; 2015 Sep; 51(9):862-9. PubMed ID: 26183400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
    Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
    Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
    Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
    Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of protein p16
    Yang H; Cao Y; Li ZM; Li YJ; Jiang WQ; Shi YX
    Oncol Lett; 2018 Nov; 16(5):6147-6155. PubMed ID: 30333880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.